Around 390 million people are infected each year with dengue fever – the world’s fastest-spreading tropical disease – more than triple the current estimate by the World Health Organisation, experts said.

Last year, Europe experienced its first sustained transmission of dengue fever since the 1920s

The new finding, based on several years of analysis, underscores the growing burden of the mosquito-borne viral disease, which is also called “breakbone fever” because of the severe pain it can cause.

There is as yet no approved vaccine or specific drug to treat dengue, which is not normally fatal but lands many victims in hospital.

Researchers from the University of Oxford and the Wellcome Trust presented their results, along with a detailed map of dengue distribution, in the journal Nature.

Their new figure includes 96 million severe cases and approximately 300 million mild or asymptomatic episodes. That compares with the WHO’s most recent estimate for overall infections of 50 to 100 million a year.

The high number of relatively mild cases offers little cause for comfort, since it suggests the reservoir of disease is far larger than expected.

Spread by the Aedes aegypti mosquito, dengue has grown rapidly along with urbanisation and globalisation because it thrives in tropical mega-cities and is easily spread in goods containing small puddles of water, such as used tyres.

Climate change is also making more parts of the planet habitable for the dengue-spreading mosquito.

As a result, half the world’s population is now exposed to the disease, mostly in the developing world – but also in parts of southern Europe and the southern US. Last year, Europe experienced its first sustained transmission of dengue fever since the 1920s with around 2,000 people infected in the Portuguese archipelago of Madeira.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.